Denmark· DK-28101346388
Benaliv
A levocabastine product containing levocabastinhydrochlorid, registered in Denmark by McNeil Denmark ApS. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Levocabastine is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AC02 (levocabastine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Levocabastine · ATC R01AC02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Levocabastinhydrochlorid
- Manufacturer
- McNeil Denmark ApS
- Country
- Denmark (DK)
- ATC code
- R01AC02
- ATC class
- Levocabastine
- Defined daily dose
- 0.6 mg, N
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101346388
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R01AC02
Levocabastine, as other registers publish it.
- GermanyLevocabastinDermapharm Ag
- GermanyLevocamedDermapharm Ag
- NetherlandsLivocab 0,5 mg/ml neusspray, suspensieKenvue Netherlands B.V.
- GermanyLivocab Direkt NasensprayKenvue Germany Gmbh
- FinlandLivostinParanova Oy
- IcelandLivostinMcNeil Sweden AB
- FinlandLivostinMcNeil / JNTL Consumer Health (Finland) Oy
- FinlandLivostinOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8fa78fe2-36cc-4eb6-99b7-59980e7cac3e GET /v1/drugs/8fa78fe2-36cc-4eb6-99b7-59980e7cac3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "næsespray, suspension",
"source": "dkma",
"strength": "50 mikrogram/dosis",
"auth_role": "DKMA",
"dk_drugid": "28101346388",
"substance": "Levocabastinhydrochlorid",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "33249"
}See everything about levocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.